KR101015860B1 - 천마 발효액을 유효성분으로 함유하는 항암제 조성물 및 이의 제조방법 - Google Patents
천마 발효액을 유효성분으로 함유하는 항암제 조성물 및 이의 제조방법 Download PDFInfo
- Publication number
- KR101015860B1 KR101015860B1 KR1020100076697A KR20100076697A KR101015860B1 KR 101015860 B1 KR101015860 B1 KR 101015860B1 KR 1020100076697 A KR1020100076697 A KR 1020100076697A KR 20100076697 A KR20100076697 A KR 20100076697A KR 101015860 B1 KR101015860 B1 KR 101015860B1
- Authority
- KR
- South Korea
- Prior art keywords
- cheonma
- sugar
- lung cancer
- fermentation broth
- fermentation
- Prior art date
Links
- 241000305491 Gastrodia elata Species 0.000 title abstract 5
- 239000007788 liquid Substances 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title description 12
- 238000000855 fermentation Methods 0.000 claims abstract description 73
- 230000004151 fermentation Effects 0.000 claims abstract description 73
- 208000020816 lung neoplasm Diseases 0.000 claims abstract description 43
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims abstract description 42
- 201000005202 lung cancer Diseases 0.000 claims abstract description 42
- 239000000203 mixture Substances 0.000 claims abstract description 35
- 238000000034 method Methods 0.000 claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 8
- 240000000111 Saccharum officinarum Species 0.000 claims abstract description 4
- 235000007201 Saccharum officinarum Nutrition 0.000 claims abstract description 4
- 238000002360 preparation method Methods 0.000 claims description 14
- 239000002246 antineoplastic agent Substances 0.000 claims description 10
- 230000002265 prevention Effects 0.000 claims description 5
- 239000011550 stock solution Substances 0.000 claims description 3
- 230000001093 anti-cancer Effects 0.000 abstract description 14
- 238000002156 mixing Methods 0.000 abstract description 7
- 239000002775 capsule Substances 0.000 abstract description 6
- 235000013305 food Nutrition 0.000 abstract description 5
- 239000006188 syrup Substances 0.000 abstract description 4
- 235000020357 syrup Nutrition 0.000 abstract description 4
- 235000013361 beverage Nutrition 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 239000007924 injection Substances 0.000 abstract description 2
- 238000002347 injection Methods 0.000 abstract description 2
- 239000000725 suspension Substances 0.000 abstract description 2
- 239000003826 tablet Substances 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 abstract 1
- 239000002304 perfume Substances 0.000 abstract 1
- 235000011888 snacks Nutrition 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 18
- 230000000694 effects Effects 0.000 description 13
- 201000011510 cancer Diseases 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 239000004480 active ingredient Substances 0.000 description 8
- 230000032683 aging Effects 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000005740 tumor formation Effects 0.000 description 6
- 210000000038 chest Anatomy 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- FLAQQSHRLBFIEZ-UHFFFAOYSA-N N-Methyl-N-nitroso-4-oxo-4-(3-pyridyl)butyl amine Chemical compound O=NN(C)CCCC(=O)C1=CC=CN=C1 FLAQQSHRLBFIEZ-UHFFFAOYSA-N 0.000 description 4
- 210000000621 bronchi Anatomy 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000002685 pulmonary effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 231100000002 MTT assay Toxicity 0.000 description 3
- 238000000134 MTT assay Methods 0.000 description 3
- 206010027476 Metastases Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 208000005718 Stomach Neoplasms Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000030833 cell death Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 206010017758 gastric cancer Diseases 0.000 description 3
- 201000007270 liver cancer Diseases 0.000 description 3
- 208000014018 liver neoplasm Diseases 0.000 description 3
- 230000009401 metastasis Effects 0.000 description 3
- 230000000391 smoking effect Effects 0.000 description 3
- 201000011549 stomach cancer Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 208000002151 Pleural effusion Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000036952 cancer formation Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 230000003370 grooming effect Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010073310 Occupational exposures Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 150000001495 arsenic compounds Chemical class 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000011976 chest X-ray Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229940093920 gynecological arsenic compound Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- MBABOKRGFJTBAE-UHFFFAOYSA-N methyl methanesulfonate Chemical compound COS(C)(=O)=O MBABOKRGFJTBAE-UHFFFAOYSA-N 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 231100000675 occupational exposure Toxicity 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229910052704 radon Inorganic materials 0.000 description 1
- SYUHGPGVQRZVTB-UHFFFAOYSA-N radon atom Chemical compound [Rn] SYUHGPGVQRZVTB-UHFFFAOYSA-N 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000013185 thoracic computed tomography Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
도 2는 본 발명의 천마 발효액의 농도에 따른 다양한 암세포에서의 세포 사멸율을 확인한 그래프이며,
도 3은 본 발명의 천마 발효액 복용에 대한 폐암의 치료경과를 흉부 단순 촬영상으로 확인한 결과이고,
(A: 복용 전, B: 복용 2년 경과 후, C: 복용 2년 6개월 경과 후)
도 4는 본 발명의 천마 발효액 복용에 대한 폐암의 치료경과를 흉부 단순 촬영상으로 확인한 결과이다.
(A: 복용 전, B: 복용 2년 경과 후, C: 복용 2년 6개월 경과 후)
Claims (6)
- 삭제
- 삭제
- 삭제
- 천마 분쇄물과 설탕을 천마 분쇄물 중량대비 설탕 1 내지 1.5 중량비로 혼합한 혼합물을 1년 내지 2년 동안 5℃ 내지 10℃의 온도에서 저온 발효숙성하여 천마 발효액을 수득하는 단계를 포함하는, 항암제 조성물의 제조방법.
- 제 4항에 있어서,
상기 설탕은 사탕수수 원액으로 만들어진 흑설탕인 것을 특징으로 하는 항암제 조성물의 제조방법. - 제 4항 또는 제 5항에 있어서,
상기 항암제 조성물은 폐암의 예방 또는 치료용인 것을 특징으로 하는 항암제 조성물의 제조방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100076697A KR101015860B1 (ko) | 2010-08-10 | 2010-08-10 | 천마 발효액을 유효성분으로 함유하는 항암제 조성물 및 이의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100076697A KR101015860B1 (ko) | 2010-08-10 | 2010-08-10 | 천마 발효액을 유효성분으로 함유하는 항암제 조성물 및 이의 제조방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101015860B1 true KR101015860B1 (ko) | 2011-02-23 |
Family
ID=43777619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100076697A KR101015860B1 (ko) | 2010-08-10 | 2010-08-10 | 천마 발효액을 유효성분으로 함유하는 항암제 조성물 및 이의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101015860B1 (ko) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101148513B1 (ko) | 2011-07-16 | 2012-05-21 | 최재홍 | 천마를 활용한 에르고티오닌 증강조성물 제조방법 |
KR101335788B1 (ko) | 2011-10-07 | 2013-12-02 | 최재홍 | 해동드립을 이용한 생천마 발효추출물을 제조하는 방법 |
CN107184825A (zh) * | 2017-04-20 | 2017-09-22 | 禹州市兴华药业有限公司 | 一种用于消除恶性肿瘤的中药粉剂及其制备方法 |
CN108498802A (zh) * | 2018-05-10 | 2018-09-07 | 西安培华学院 | 用于治疗非小细胞肺癌的药物组合物及其制剂 |
CN111632149A (zh) * | 2020-05-14 | 2020-09-08 | 青岛市肿瘤医院 | 一种治疗肺癌的药物组合物及其制剂 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050062723A (ko) * | 2003-12-22 | 2005-06-27 | 문홍진 | 산야초를 이용한 발효숙성 조성물 및 그의 제조방법 |
KR20070028269A (ko) * | 2006-11-15 | 2007-03-12 | 김은순 | 세균감염 |
KR20080109356A (ko) * | 2007-06-13 | 2008-12-17 | 삼성생약주식회사 | 펠리누스 린테우스 균사체 및 천마의 혼합 추출물을 유효성분으로 함유하는 증식질환의 예방 또는 치료용 약학적 조성물 |
-
2010
- 2010-08-10 KR KR1020100076697A patent/KR101015860B1/ko active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050062723A (ko) * | 2003-12-22 | 2005-06-27 | 문홍진 | 산야초를 이용한 발효숙성 조성물 및 그의 제조방법 |
KR20070028269A (ko) * | 2006-11-15 | 2007-03-12 | 김은순 | 세균감염 |
KR20080109356A (ko) * | 2007-06-13 | 2008-12-17 | 삼성생약주식회사 | 펠리누스 린테우스 균사체 및 천마의 혼합 추출물을 유효성분으로 함유하는 증식질환의 예방 또는 치료용 약학적 조성물 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101148513B1 (ko) | 2011-07-16 | 2012-05-21 | 최재홍 | 천마를 활용한 에르고티오닌 증강조성물 제조방법 |
KR101335788B1 (ko) | 2011-10-07 | 2013-12-02 | 최재홍 | 해동드립을 이용한 생천마 발효추출물을 제조하는 방법 |
CN107184825A (zh) * | 2017-04-20 | 2017-09-22 | 禹州市兴华药业有限公司 | 一种用于消除恶性肿瘤的中药粉剂及其制备方法 |
CN108498802A (zh) * | 2018-05-10 | 2018-09-07 | 西安培华学院 | 用于治疗非小细胞肺癌的药物组合物及其制剂 |
CN111632149A (zh) * | 2020-05-14 | 2020-09-08 | 青岛市肿瘤医院 | 一种治疗肺癌的药物组合物及其制剂 |
CN111632149B (zh) * | 2020-05-14 | 2022-09-30 | 青岛市肿瘤医院 | 一种治疗肺癌的药物组合物及其制剂 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101160943B1 (ko) | 상황버섯 균사체와 산삼 배양근 혼합 추출물을 유효성분으로 함유하는 암 예방 및 개선용 건강기능 식품 조성물 | |
KR101015860B1 (ko) | 천마 발효액을 유효성분으로 함유하는 항암제 조성물 및 이의 제조방법 | |
KR101396458B1 (ko) | 천년초 발효물 함유 식품 또는 음료 조성물 | |
KR20170109703A (ko) | 혼합 생약 추출물의 분획물을 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물 | |
CN102186488B (zh) | 齿裂黄鹌菜提取物用于制备肝功能改善用药物组合物及用于制备肝功能改善用健康功能食品组合物的用途 | |
KR101033671B1 (ko) | 상황버섯과 동충하초를 포함하는 항암용 건강식품 | |
KR102229547B1 (ko) | 엉겅퀴 및 민들레로 이루어진 혼합물을 함유하는 간질환의 개선, 예방 또는 치료용 조성물 | |
KR101769774B1 (ko) | 종양 예방 또는 개선용 건강기능성 식품 | |
KR102414431B1 (ko) | 엉겅퀴, 민들레, 여주, 돼지감자, 양파, 꾸지뽕, 아로니아 및 생강을 포함하는 당뇨의 예방, 치료 또는 개선용 조성물 | |
KR102185011B1 (ko) | 엉겅퀴를 함유하는 간질환의 개선, 예방 또는 치료용 조성물 | |
KR101759637B1 (ko) | 간암 예방용 건강기능성 식품 | |
KR101760163B1 (ko) | 톱니모자반 추출물을 유효성분으로 함유하는 항비만용 조성물 | |
KR102302045B1 (ko) | 엉겅퀴 및 양파를 포함하는 혼합물을 함유하는 간질환의 개선, 예방 또는 치료용 조성물 | |
KR20140041187A (ko) | 얼레지 추출물을 포함하는 항암 조성물 | |
KR102085582B1 (ko) | 쑥부지깽이 속 추출물을 유효성분으로 함유하는 항종양 또는 항종양 면역작용 유도용 조성물 | |
KR101597187B1 (ko) | 위암에 대한 항암 활성을 갖는 천련자 추출물을 유효 성분으로 함유하는 조성물 | |
KR101760685B1 (ko) | 위암 예방용 건강기능성 식품 | |
JP5008813B2 (ja) | クビレヅタ抽出物を含有する抗皮膚癌剤 | |
KR102039623B1 (ko) | 간세포 보호용 엉겅퀴 과립 조성물 및 이의 제조방법 | |
KR102223638B1 (ko) | 은 화합물과 착화제를 함유하는 항균 조성물 및 삼칠근 추출물을 유효성분으로 포함하는 혈중 전립선 특이항원 안정화제 | |
KR101257909B1 (ko) | 상황버섯 균사체와 산삼 배양근 혼합 추출물을 유효성분으로 함유하는 폐암 예방 또는 치료용 약학적 조성물 | |
KR102185006B1 (ko) | 엉겅퀴, 도라지 및 더덕이 포함된 혼합물을 함유하는 천식 및 혈관질환의 개선, 예방 또는 치료용 조성물 | |
KR101959735B1 (ko) | 잇꽃씨 추출물을 유효성분으로 포함하는 대장암에 대한 시스플라틴의 항암활성 증진용 조성물 | |
KR20180118412A (ko) | 밀리타리스 동충하초 에틸아세테이트 분획물을 유효성분으로 하는 간암의 예방 또는 치료용 조성물 | |
KR20170055366A (ko) | 흰민들레 뿌리 추출물을 유효성분으로 포함하는 비만 예방 또는 치료용 약학적 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20131219 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20150210 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20160211 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20170210 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20180209 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20190211 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20200218 Year of fee payment: 10 |